A Houston space medicine research organization has partnered with a video game maker that has created surgery simulation technology. Photo via levelex.com

A Houston-based organization affiliated with NASA has teamed up with a video game company to advance virtual simulation in space medicine.

The Translational Research Institute for Space Health, known as TRISH, in partnership with NASA in a consortium led by Baylor College of Medicine, California Institute of Technology in Pasadena, and Massachusetts Institute of Technology in Cambridge has advanced a new approach for space medicine using video game technology by collaborating with video game company, Level Ex.

"We discovered Level Ex through a process of landscaping the many virtual simulation companies that were out there," says Andrew Peterman Director of Information System at TRISH. "We especially noted those that were on the cutting edge of the technology."

Based in Houston, TRISH aims to collaborate with the best and the brightest to revolutionize space health, providing grants to companies with innovative concepts. With Level Ex, they found a new approach to decode earthly medical technologies in space.

Level Ex, a Chicago-based company created in 2015 was founded to provide training games for doctors to use to practice surgeries and procedures. The games are interactive, with the virtual patient reacting to the actions of the player. The training simulations consist of in-depth and physics-driven medical simulations that are verified by doctors in their advisory board.

"We're hoping to completely change the ways that doctors stay up to speed," says Level Ex founder-and-CEO Sam Glassnberg.

With their ongoing collaboration with TRISH, they have a challenge that's out of this world. In space, astronauts have limited space for medical tools and run on a limited crew. This makes providing basic medical training to all astronauts especially important.

Especially since the body begins to react to the new environmental conditions of space missions. The effects can be small or lead to new changes or challenges for astronauts who take on long-range missions. Astronauts may see their bodies slowly start to lose bone and muscle mass. Their fluid begins to shift toward their head, leading to increased risks of hypertension and thrombosis.

All of these are challenges NASA is working to address with the help of gaming technology from Level Ex that innovates the technology with higher-level capability and training. Combining video game technology and medical simulation applications to incorporate and explore the interplay of environmental conditions found in space.

"What we really liked about Level Ex is that they have an amazing team both on the clinical and technical side, says Peterman. "They are a group of former big-name game developers who along with clinical experts have married technology and medicine with their platform producing full in engine physics-driven real simulations rather than video playback."

The astronauts will train using simulations that allow them to practice a procedure in zero gravity conditions and even simulate the gravity conditions of Mars. The game will also allow astronauts to get their own on-screen avatar with their medical information thus allowing fellow astronauts to gain more practice and experience with fewer variables in space.

The advanced medical simulation platform has potential for commercial uses on earth, improving the range of the technology to simulate new, rare, and complex scenarios across a range of medical specialties, allowing doctors to practice a range of difficult scenarios without putting patient lives at risk.

Peterman says that the partnership is expected to continue into the future for immediate applications along with other innovations in astronaut healthcare, including autonomous frameworks to provide medical knowledge in outer space.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston's Ion District to expand with new research and tech space, The Arc

coming soon

Houston's Ion District is set to expand with the addition of a nearly 200,000-square-foot research and technology facility, The Arc at the Ion District.

Rice Real Estate Company and Lincoln Property Company are expected to break ground on the state-of-the-art facility in Q2 2026 with a completion target set for Q1 2028, according to a news release.

Rice University, the new facility's lead tenant, will occupy almost 30,000 square feet of office and lab space in The Arc, which will share a plaza with the Ion and is intended to "extend the district’s success as a hub for innovative ideas and collaboration." Rice research at The Arc will focus on energy, artificial intelligence, data science, robotics and computational engineering, according to the release.

“The Arc will offer Rice the opportunity to deepen its commitment to fostering world-changing innovation by bringing our leading minds and breakthrough discoveries into direct engagement with Houston’s thriving entrepreneurial ecosystem,” Rice President Reginald DesRoches said in the release. “Working side by side with industry experts and actual end users at the Ion District uniquely positions our faculty and students to form partnerships and collaborations that might not be possible elsewhere.”

Developers of the project are targeting LEED Gold certification by incorporating smart building automation and energy-saving features into The Arc's design. Tenants will have the opportunity to lease flexible floor plans ranging from 28,000 to 31,000 square feet with 15-foot-high ceilings. The property will also feature a gym, an amenity lounge, conference and meeting spaces, outdoor plazas, underground parking and on-site retail and dining.

Preleasing has begun for organizations interested in joining Rice in the building.

“The Arc at the Ion District will be more than a building—it will be a catalyst for the partnerships, innovations and discoveries that will define Houston’s future in science and technology,” Ken Jett, president of Rice Real Estate Company, added in the release. “By expanding our urban innovation ecosystem, The Arc will attract leading organizations and talent to Houston, further strengthening our city’s position as a hub for scientific and entrepreneurial progress.”

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”